Selected research
Industry Growth & Trends
Global Laboratory Developed Tests (LDT) Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Laboratory Developed Tests (LDT) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Laboratory Developed Tests (LDT) market include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Laboratory Developed Tests (LDT) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Laboratory Developed Tests (LDT) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Laboratory Developed Tests (LDT) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Laboratory Developed Tests (LDT).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Laboratory Developed Tests (LDT) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Laboratory Developed Tests (LDT) Market by Company
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Adaptive Biotechnologies
Biodesix
Berry Oncology
Genetron Health
Laboratory Developed Tests (LDT) Segment by Type
Clinical Biochemistry
Hematology
Immunology
Molecular Diagnostics
Other
Laboratory Developed Tests (LDT) Segment by Application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Other
Laboratory Developed Tests (LDT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Developed Tests (LDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory Developed Tests (LDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Developed Tests (LDT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Laboratory Developed Tests (LDT) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Clinical Biochemistry
- Hematology
- Immunology
- Molecular Diagnostics
- Other
Applications
- Hospitals Laboratory
- Clinical Research Organizations
- Academic Institutes
- Specialty Diagnostic Centers
- Other
Companies covered
- Quest Diagnostics
- Thermo Fisher
- Waters Corporation
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Adaptive Biotechnologies
- Biodesix
- Berry Oncology
- Genetron Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Laboratory Developed Tests (LDT) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Laboratory Developed Tests (LDT) Market Size by Region (2021-2032)
- 1.4.1 Global Laboratory Developed Tests (LDT) Market Size by Region (2021-2026)
- 1.4.2 Global Laboratory Developed Tests (LDT) Market Size by Region (2027-2032)
- 1.5 Key Regions Laboratory Developed Tests (LDT) Market Size (2021-2032)
- 1.5.1 North America Laboratory Developed Tests (LDT) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Laboratory Developed Tests (LDT) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size Growth Rate (2021-2032)
- 1.5.4 South America Laboratory Developed Tests (LDT) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Laboratory Developed Tests (LDT) Market Size Growth Rate (2021-2032)
2 Laboratory Developed Tests (LDT) Market by Type
- 2.1 Type Introduction
- 2.1.1 Clinical Biochemistry
- 2.1.2 Hematology
- 2.1.3 Immunology
- 2.1.4 Molecular Diagnostics
- 2.1.5 Other
- 2.2 Global Laboratory Developed Tests (LDT) Market Size by Type
- 2.2.1 Global Laboratory Developed Tests (LDT) Market Size Overview by Type (2021-2032)
- 2.2.2 Global Laboratory Developed Tests (LDT) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Laboratory Developed Tests (LDT) Market Size Forecasted by Type (2027-2032)
- 2.3 Global Laboratory Developed Tests (LDT) Market Size by Regions
- 2.3.1 North America Laboratory Developed Tests (LDT) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Laboratory Developed Tests (LDT) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Laboratory Developed Tests (LDT) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Laboratory Developed Tests (LDT) Market Size Breakdown by Type (2021-2026)
3 Laboratory Developed Tests (LDT) Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals Laboratory
- 3.1.2 Clinical Research Organizations
- 3.1.3 Academic Institutes
- 3.1.4 Specialty Diagnostic Centers
- 3.1.5 Other
- 3.2 Global Laboratory Developed Tests (LDT) Market Size by Application
- 3.2.1 Global Laboratory Developed Tests (LDT) Market Size Overview by Application (2021-2032)
- 3.2.2 Global Laboratory Developed Tests (LDT) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Laboratory Developed Tests (LDT) Market Size Forecasted by Application (2027-2032)
- 3.3 Global Laboratory Developed Tests (LDT) Market Size by Regions
- 3.3.1 North America Laboratory Developed Tests (LDT) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Laboratory Developed Tests (LDT) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Laboratory Developed Tests (LDT) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Laboratory Developed Tests (LDT) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Laboratory Developed Tests (LDT) Industry Trends
- 4.2 Laboratory Developed Tests (LDT) Industry Drivers
- 4.3 Laboratory Developed Tests (LDT) Industry Opportunities and Challenges
- 4.4 Laboratory Developed Tests (LDT) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Laboratory Developed Tests (LDT) Revenue (2021-2026)
- 5.2 Global Laboratory Developed Tests (LDT) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Laboratory Developed Tests (LDT) Key Company Headquarters & Area Served
- 5.4 Global Laboratory Developed Tests (LDT) Company, Product Type & Application
- 5.5 Global Laboratory Developed Tests (LDT) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Laboratory Developed Tests (LDT) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Laboratory Developed Tests (LDT) Players Market Share by Revenue in 2025
- 5.6.3 2025 Laboratory Developed Tests (LDT) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Quest Diagnostics
- 6.1.1 Quest Diagnostics Company Information
- 6.1.2 Quest Diagnostics Business Overview
- 6.1.3 Quest Diagnostics Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio
- 6.1.5 Quest Diagnostics Recent Developments
- 6.2 Thermo Fisher
- 6.2.1 Thermo Fisher Company Information
- 6.2.2 Thermo Fisher Business Overview
- 6.2.3 Thermo Fisher Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio
- 6.2.5 Thermo Fisher Recent Developments
- 6.3 Waters Corporation
- 6.3.1 Waters Corporation Company Information
- 6.3.2 Waters Corporation Business Overview
- 6.3.3 Waters Corporation Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio
- 6.3.5 Waters Corporation Recent Developments
- 6.4 Roche
- 6.4.1 Roche Company Information
- 6.4.2 Roche Business Overview
- 6.4.3 Roche Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Roche Laboratory Developed Tests (LDT) Product Portfolio
- 6.4.5 Roche Recent Developments
- 6.5 Illumina
- 6.5.1 Illumina Company Information
- 6.5.2 Illumina Business Overview
- 6.5.3 Illumina Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Illumina Laboratory Developed Tests (LDT) Product Portfolio
- 6.5.5 Illumina Recent Developments
- 6.6 Qiagen
- 6.6.1 Qiagen Company Information
- 6.6.2 Qiagen Business Overview
- 6.6.3 Qiagen Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Qiagen Laboratory Developed Tests (LDT) Product Portfolio
- 6.6.5 Qiagen Recent Developments
- 6.7 Eurofins
- 6.7.1 Eurofins Company Information
- 6.7.2 Eurofins Business Overview
- 6.7.3 Eurofins Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Eurofins Laboratory Developed Tests (LDT) Product Portfolio
- 6.7.5 Eurofins Recent Developments
- 6.8 Guardant Health
- 6.8.1 Guardant Health Company Information
- 6.8.2 Guardant Health Business Overview
- 6.8.3 Guardant Health Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Guardant Health Laboratory Developed Tests (LDT) Product Portfolio
- 6.8.5 Guardant Health Recent Developments
- 6.9 Adaptive Biotechnologies
- 6.9.1 Adaptive Biotechnologies Company Information
- 6.9.2 Adaptive Biotechnologies Business Overview
- 6.9.3 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio
- 6.9.5 Adaptive Biotechnologies Recent Developments
- 6.10 Biodesix
- 6.10.1 Biodesix Company Information
- 6.10.2 Biodesix Business Overview
- 6.10.3 Biodesix Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Biodesix Laboratory Developed Tests (LDT) Product Portfolio
- 6.10.5 Biodesix Recent Developments
- 6.11 Berry Oncology
- 6.11.1 Berry Oncology Company Information
- 6.11.2 Berry Oncology Business Overview
- 6.11.3 Berry Oncology Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio
- 6.11.5 Berry Oncology Recent Developments
- 6.12 Genetron Health
- 6.12.1 Genetron Health Company Information
- 6.12.2 Genetron Health Business Overview
- 6.12.3 Genetron Health Laboratory Developed Tests (LDT) Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Genetron Health Laboratory Developed Tests (LDT) Product Portfolio
- 6.12.5 Genetron Health Recent Developments
7 North America
- 7.1 North America Laboratory Developed Tests (LDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 7.3 North America Laboratory Developed Tests (LDT) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Laboratory Developed Tests (LDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 8.3 Europe Laboratory Developed Tests (LDT) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Laboratory Developed Tests (LDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Laboratory Developed Tests (LDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 10.3 South America Laboratory Developed Tests (LDT) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Laboratory Developed Tests (LDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Laboratory Developed Tests (LDT) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst